Loyola University Medical Center has launched the first clinical trial in the Midwest of an experimental melanoma treatment that genetically engineers a patient’s immune system to fight the deadly cancer. A batch of the immune [...]
Engineering the Immune System to Fight Melanoma
- October 2, 2012
- Engineering the Immune System to Fight Melanoma
- Posted by innovation at 8:54 am
- No Responses
- Biomedical Engineering, Cancers, Cutting-edge, Disease A-C, Emerging Technologies, Health, Innovation, Promising, Skin Cancer, Technology
- Tagged with: american cancer society, Amy Wagers, cancer, Clinical trial, common fatal malignancy, Engineering the Immune System, engineering the immune system to fight melanoma, five-year survival rate, Health, high-dose chemotherapy, hydrogen sulfide could greatly enhance plant growth, Immune system, latest streaming news, loyola university, Loyola University Medical Center, melanoma, Permian, Permian–Triassic extinction event, Richard Lee, t, t cells, Tumor, tumor cells, university health system, university medical center




